FLT3 GENE MUTATION

Clinical trials for FLT3 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new FLT3 GENE MUTATION trials appear

Sign up with your email to follow new studies for FLT3 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New Triple-Threat drug combo tested to control aggressive blood cancer

Disease control Recruiting now

This study is testing a combination of three drugs (gilteritinib, venetoclax, and azacitidine) for adults and teens newly diagnosed with a fast-growing blood cancer called AML, who have a specific genetic change (FLT3 mutation) and are healthy enough for strong treatment. The mai…

Matched conditions: FLT3 GENE MUTATION

Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

FLT3 GENE MUTATION

Get alerted when new FLT3 GENE MUTATION trials appear

New Triple-Threat drug combo tested to control aggressive blood cancer